by Primrose Bio | May 12, 2025 | Scientific Posters
ABSTRACT: Primrose Bio’s Pfenex Expression Technology® (Pfenex) platform has established itself as a robust, scalable solution for recombinant protein production, as evidenced by its role in six commercially approved products. Integrating sophisticated... 
by Primrose Bio | May 8, 2025 | Events
Primrose Bio joined global leaders in Berlin for the 3rd Annual mRNA Process Development & Manufacturing Summit, showcasing our innovations in mRNA manufacturing. On Day 1, Advisor Khaled Yamout presented “Smarter RNA Polymerase Selection for... 
by Primrose Bio | Apr 25, 2025 | Events
Primrose Bio was proud to exhibit and present at the World Vaccine Congress 2025, held April 22–25 in Washington, D.C. Our team shared insights into next-generation solutions for biotherapeutics and vaccine manufacturing, highlighting our Prima RNApols™ platform... 
by Primrose Bio | Mar 26, 2025 | Featured, Press
Significantly increased quality and lower manufacturing costs for long template mRNAs San Diego, Calif. March 26, 2025 – Primrose Bio, Inc. (“Primrose”), a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApols™... 
by Primrose Bio | Mar 20, 2025 | Events
Primrose Bio was proud to participate in Bio-Europe Spring 2025, held March 17–19 in Italy. Representing the team, Alec Tzianabos connected with global partners to discuss our scalable, efficient, and cost-effective manufacturing solutions for complex biologics....